Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$48.3 - $68.06 $86,940 - $122,508
1,800 New
1,800 $116,000
Q2 2022

Aug 15, 2022

SELL
$52.13 - $93.81 $83,460 - $150,189
-1,601 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$64.92 - $99.47 $103,936 - $159,251
1,601 New
1,601 $145,000
Q3 2021

Nov 15, 2021

SELL
$71.29 - $95.99 $59,099 - $79,575
-829 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$79.62 - $114.85 $27,867 - $40,197
350 Added 73.07%
829 $77,000
Q1 2021

May 17, 2021

BUY
$77.91 - $125.92 $37,318 - $60,315
479 New
479 $51,000

Others Institutions Holding NARI

About Inari Medical, Inc.


  • Ticker NARI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,389,700
  • Market Cap $2.96B
  • Description
  • Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of ...
More about NARI
Track This Portfolio

Track Point72 Hong Kong LTD Portfolio

Follow Point72 Hong Kong LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.